{"transactions":[{"id":934206,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2026-01-21T16:37:14.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":8335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":8335,"derivative":{"exercise_price":1.55,"exercise_date":"2026-01-08","expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":8335},"source":{"system":"sec-edgar","filing":"0001493152-26-003103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315226003103/ownership.xml","form_type":"4"}},{"id":1298769,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2025-01-21T06:06:14.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":27055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":27055,"derivative":{"exercise_price":0.9678,"exercise_date":"2025-01-15","expiration_date":"2027-01-15","underlying":"Common Stock","underlying_shares":27055},"source":{"system":"sec-edgar","filing":"0001493152-25-002880","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315225002880/ownership.xml","form_type":"4"}},{"id":1675196,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2024-01-19T17:24:01.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately."}],"balance_after":12500,"derivative":{"exercise_price":3.61,"exercise_date":"2024-01-17","expiration_date":"2026-01-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-24-003099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315224003099/ownership.xml","form_type":"4"}},{"id":1781035,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T11:08:08.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":0.64,"value":5120.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-23-032583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223032583/ownership.xml","form_type":"4"}},{"id":1785859,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T10:45:57.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":6700,"price":0.71,"value":4757.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001493152-23-031935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223031935/ownership.xml","form_type":"4"}},{"id":1785858,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-07T10:45:57.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":0.7,"value":210.0,"ownership":{"direct":true},"balance_after":300,"source":{"system":"sec-edgar","filing":"0001493152-23-031935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223031935/ownership.xml","form_type":"4"}},{"id":1963264,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2023-03-08T06:20:23.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":18875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43875,"derivative":{"exercise_price":0.24,"exercise_date":"2023-01-25","expiration_date":"2025-01-25","underlying":"Common Stock","underlying_shares":18875},"source":{"system":"sec-edgar","filing":"0001493152-23-006965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315223006965/ownership.xml","form_type":"4"}},{"id":2369041,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option","published_at":"2022-02-28T06:04:31.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":3.72,"exercise_date":"2022-01-03","expiration_date":"2025-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-005547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315222005547/ownership.xml","form_type":"4"}},{"id":3987674,"issuer":{"id":8560,"kind":"organization","name":"Bone Biologics Corp"},"owners":[{"id":69057,"kind":"person","name":"Walsh Deina H","position":1,"cik":"0001651572","reported_name":"Walsh Deina H","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-20T16:14:13.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":28426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 28,426 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person\nis still providing services to the issuer on the respective date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 16, 2018, the Reporting Person was granted 28,426 shares of restricted stock units which will become fully vested 2 years from the grant date on February 16, 2020, provided the Reporting Person\nis still providing services to the issuer on the respective date."}],"balance_after":39530,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":28426},"source":{"system":"sec-edgar","filing":"0001493152-18-003653","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651572/000149315218003653/form4.xml","form_type":"4"}}]}